Physician profile
Ritu Rohatgi
NPI 1205841913
$495.41
in general payments reported to CMS, 2019-2025
18 companies · $87.01 in 2025
The $87.01 reported for 2025 was less than what a typical Geriatric Medicine (Family Medicine) provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $46.99 · 2022: $74.20 · 2023: $132 · 2024: $155 · 2025: $87.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $100.56 | 2020-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.67 | 2022-2023 | Xifaxan |
| Axsome Therapeutics, INC. | $39.22 | 2024 | Auvelity |
| Astrazeneca Pharmaceuticals LP | $34.18 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $32.93 | 2024-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $31.89 | 2022 | |
| Novo Nordisk INC | $31.58 | 2022-2023 | Wegovy |
| Phathom Pharmaceuticals, INC. | $20.13 | 2025 | Voquezna |
| Abbvie INC. | $18.90 | 2024 | |
| Lilly USA, LLC | $18.79 | 2020 | |
| Vanda Pharmaceuticals INC. | $17.96 | 2024 | Fanapt |
| Idorsia Pharmaceuticals US INC | $17.96 | 2023 | Quviviq |
| Exact Sciences Corporation | $17.07 | 2024 | Cologuard Collection Kit |
| Avvisto Therapeutics, LLC | $15.27 | 2025 | Cycloset |
| Shield Therapeutics INC | $14.98 | 2023 | Accrufer |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13.67 | 2024 | Watchman Flx |
| Teva Pharmaceuticals USA, INC. | $13.43 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ritu Rohatgi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.